Novo Nordisk shares rose sharply after the Danish pharmaceutical giant said an experimental weight-loss shot helped patients lose 22% of their body weight in a clinical trial.
Novo Nordisk Shares Surge on New Obesity Drug Results
Related Posts
Some Toyota and Ford cars are being recalled in Canada. Here’s why – National | Globalnews.ca
February 5, 2025
3:21 pm
Nylander says hat trick ‘super special’ in Calgary | Globalnews.ca
February 5, 2025
9:35 am